136 related articles for article (PubMed ID: 6318996)
1. Pseudouridine determination in blood serum as tumor marker.
Salvatore F; Russo T; Colonna A; Cimino L; Mazzacca G; Cimino F
Cancer Detect Prev; 1983; 6(6):531-6. PubMed ID: 6318996
[TBL] [Abstract][Full Text] [Related]
2. The use of receiver operating characteristic (ROC) curves analysis in the evaluation of the diagnostic efficiency of serum pseudouridine as a tumor marker.
Savoia M; Pane F; Fortunato G; Salvatore F; Sacchetti L
Ital J Biochem; 1988; 37(2):119-27. PubMed ID: 3403212
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of N2, N2-dimethylguanosine and pseudouridine as determined by radioimmunoassay for patients with malignancy.
Levine L; Waalkes TP; Stolbach L
J Natl Cancer Inst; 1975 Feb; 54(2):341-3. PubMed ID: 1117461
[TBL] [Abstract][Full Text] [Related]
4. Antithrombin III profiles in malignancy, relationship primary tumors and metastatic sites.
Honegger H; Anderson N; Hewitt LA; Tullis JL
Thromb Haemost; 1981 Aug; 46(2):500-3. PubMed ID: 7302888
[TBL] [Abstract][Full Text] [Related]
5. Two-dimensional acrylamide gel electrophoresis of cancer-patient serum proteins.
Wright GL
Ann Clin Lab Sci; 1974; 4(4):281-93. PubMed ID: 4376659
[TBL] [Abstract][Full Text] [Related]
6. Serum pseudouridine as a biochemical marker in the development of AKR mouse lymphoma.
Russo T; Colonna A; Salvatore F; Cimino F; Bridges S; Gurgo C
Cancer Res; 1984 Jun; 44(6):2567-70. PubMed ID: 6722793
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of a 21-kDa protein in the circulation of tumor-bearing patients.
Shalitin C; Epelbaum R; Moskovitz B; Segal R; Valansi C; Werner M; Livne PM
Cancer Detect Prev; 1994; 18(5):357-65. PubMed ID: 7812982
[TBL] [Abstract][Full Text] [Related]
8. Serum pseudouridine concentration as a marker of gastrointestinal cancer.
Higley B; De Mello J; Oakes DJ; Giles GR
Clin Oncol; 1982 Dec; 8(4):305-12. PubMed ID: 7168923
[No Abstract] [Full Text] [Related]
9. Clinical value of urinary and serum pseudouridine in diagnosis and monitoring of primary liver cancer.
Tu Z; Xu S; Wu M
Chin Med J (Engl); 1995 Mar; 108(3):204-8. PubMed ID: 7796629
[TBL] [Abstract][Full Text] [Related]
10. Pseudouridine: a modified nucleoside as biological marker in malignant lymphomas.
Rasmuson T; Björk GR
Cancer Detect Prev; 1983; 6(1-2):293-6. PubMed ID: 6883387
[TBL] [Abstract][Full Text] [Related]
11. [The clinical significance of pseudouridine determination of the urine in children and adolescents].
Graf N; Bach K; Frisch B; Haas HJ; Sitzmann FC
Klin Padiatr; 1989; 201(3):154-62. PubMed ID: 2739340
[TBL] [Abstract][Full Text] [Related]
12. [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].
Tang JH; Zhao JH; Gong JP; Qin JW; Pan LQ; Xu ZY
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):210-4. PubMed ID: 17649639
[TBL] [Abstract][Full Text] [Related]
13. [Relationship of serum level of creatine kinase of MB type to cardiac function of patients with advanced tumors and its prognostic value].
Wu XM; Hu CZ; Li N; Zhu JQ; Wu YF
Ai Zheng; 2005 Apr; 24(4):506-8. PubMed ID: 15820080
[TBL] [Abstract][Full Text] [Related]
14. Proceedings: Ectopic parathyroid hormone-producing tumors.
Fujita T
Calcif Tissue Res; 1974; 15(2):154. PubMed ID: 4367483
[No Abstract] [Full Text] [Related]
15. Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinoma.
Hsu PI; Chow NH; Lai KH; Yang HB; Chan SH; Lin XZ; Cheng JS; Huang JS; Ger LP; Huang SM; Yen MY; Yang YF
Anticancer Res; 1997; 17(4A):2803-9. PubMed ID: 9252719
[TBL] [Abstract][Full Text] [Related]
16. [Behavior of serum sialic acid levels at various stages of neoplastic disease].
Adamo V; Altavilla G; Caristi N; Chillemi S; Giacobello T; Scalisi R; Palmara D
Minerva Med; 1985 Nov; 76(43):2067-70. PubMed ID: 4069416
[TBL] [Abstract][Full Text] [Related]
17. Serum pseudouridine as a biochemical marker in patients with hepatocellular carcinoma.
Amuro Y; Nakaoka H; Shimomura S; Fujikura M; Yamamoto T; Tamura S; Hada T; Higashino K
Clin Chim Acta; 1988 Dec; 178(2):151-8. PubMed ID: 2854011
[TBL] [Abstract][Full Text] [Related]
18. [Determination of beta2-microglobulin in breast, lung, colorectal and ENT carcinoma (author's transl)].
Viot G; Leca M; Moll JL; de Salvador F; Namer M; Demard F; Krebs BP
Pathol Biol (Paris); 1978 Sep; 26(6):351-2. PubMed ID: 83582
[TBL] [Abstract][Full Text] [Related]
19. Determination of pseudouridine and other nucleosides in human blood serum by high-performance liquid chromatography.
Colonna A; Russo T; Esposito F; Salvatore F; Cimino F
Anal Biochem; 1983 Apr; 130(1):19-26. PubMed ID: 6869800
[TBL] [Abstract][Full Text] [Related]
20. [Alpha 1-antitrypsin as a tumor marker].
Schena M; Quadri A; Ragazzoni G; Corti P
Quad Sclavo Diagn; 1985 Mar; 21(1):87-96. PubMed ID: 3877314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]